Drug Quality Study (DQS)
As human spaceflight expands, flight crews must have safe and effective drugs for long-duration spaceflight. In the past, crews have relied upon frequent resupply of onboard pharmaceuticals and as a result, there has been little study of the effects of long-term exposure of pharmaceuticals to the space environment. A few studies of long-term effects of space radiation on drug stability have shown that a significant number of drugs degrade. Studies during the COVID-19 pandemic have shown that drug quality can be an issue even for pharmaceuticals that remain on Earth. CIC Pharmaceutical Sciences presents these Drug Quality Studies to help scientists focus on the problem.
Assessment of Vecuronium Quality Using Near-Infrared Spectrometry
Potential Process Control Issues With Abatacept
Variability in Content of Hydrocortisone Sodium Succinate
Quality Variations in Thyrotropin Alfa
Spectrometric Analysis of Dantrolene Sodium
Spectral Intra-Lot and Inter-Lot Variability in Carfilzomib
Spectrometric Analysis of Process Variations in Remifentanil
Potential Process Control Issues with Pemetrexed
Variability in Content of Piperacillin and Tazobactam Injection
Lack of Content Uniformity in MMR Vaccine
FTNIR Spectrometry of Micafungin Sodium Quality
Levothyroxine Variations by Process Analytical Technology
Spectrometric Results of Process Variations in Dacarbazine
Intra-Lot and Inter-Lot Variability in Cosyntropin